alxo stock forecast

Policy, Alx Oncology Holdings Inc Stock Price Forecast for 2021, Alx Oncology Holdings Inc Stock Price Forecast for 2022, Alx Oncology Holdings Inc Stock Price Forecast for 2023, Alx Oncology Holdings Inc Stock Price Forecast for 2024, Alx Oncology Holdings Inc Stock Price Forecast for 2025, Alx Oncology Holdings Inc Stock Price Forecast for 2026. ALXO stock future price, ALXO stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, BlackRock Inc., Artal Group S.A., Orbimed Advisors LLC, Nicholas Investment Partners LP, Tri Locum Partners LP, Bank of New York Mellon Corp, and UBS Asset Management Americas Inc.. View insider buying and selling activity for ALX Oncology or or view top insider-buying stocks. Sign in, Not a member? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ALX Oncology in the last twelve months. stock price predictions may be different due to the different analyzed time series. View analyst ratings for ALX Oncology or view top-rated stocks. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. View live ALX ONCOLOGY HLDGS INC chart to track its stock's price action. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The Ticker name says... why is the price of CAKE keep going up, when restaurants are going out of business everywhere. If we look at the company’s 10-day average daily trading volume, we find that it … ALX Oncology Holdings Inc. (NASDAQ:ALXO) released its earnings results on Tuesday, November, 17th. If you are looking for stocks with good return, Alx Oncology Holdings Inc can be a profitable investment option. 173.206 USD in ALX Oncology Holdings Inc NASDAQ Updated Mar 10, 2021 10:30 PM. ALX Oncology saw a increase in short interest during the month of February. Yes. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Alx … Learn more. Alx Oncology Holdings Inc stock forecast, View our full suite of financial calendars and market data tables, all for free. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. This site is off balance? ALXO prediction, "ALXO" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Our Accessibility Statement The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . ), ALX Oncology has received 3 “underperform” votes. On average, 4 Wall Street analysts forecast ALXO's earnings for 2021 to be $-67,742,614, with the lowest ALXO earnings forecast at $-90,200,261, and the highest ALXO earnings forecast at $-58,408,366. The 12-month stock price forecast is 98.83, which is an increase of 29.48% from the latest price. Get the latest ALX Oncology Holdings Inc. ALXO detailed stock quotes, stock data, Real-Time ECN, charts, stats and … Alx Oncology Holdings Inc technical analysis, What is the Forecast Price for ALXO (ALXO) Stock Monday ... TARS,ALXO Stock Quote. Be professionals !! Have Insiders Been Buying ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares This Year? As of February 26th, there was short interest totaling 990,000 shares, an increase of 27.4% from the February 11th total of 776,800 shares. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. ALX Oncology is headquartered at 866 MALCOLM ROAD SUITE 100, BURLINGAME CA, 94010. ALX Oncology has received 75.00% “outperform” votes from our community. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings. Question Box: Compare Top Brokerages Here. * Our share forecasts and predictions are made by, Alx Oncology Holdings Inc Forecast. ALX Oncology's stock is owned by a number of institutional and retail investors. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. View all of ALXO's competitors. The company issued 8,000,000 shares at a price of $15.00-$17.00 per share. What is the Forecast Price for ALX Oncology Holdings Inc (ALXO) Stock? Export data to Excel for your own analysis. (ALXO) raised $128 million in an IPO on Friday, July 17th 2020. There are currently 6 buy ratings for the stock. This suggests a possible upside of 16.1% from the stock's current price. According to analysts' consensus price target of $89.60, ALX Oncology has a forecasted upside of 16.1% from its current price of $77.15. Specifically, they have bought $1,520,000.00 in company stock and sold $549,150.00 in company stock. The ALXO stock price is -20.65% off its 52-week high price of $52 and 35.01% above the 52-week low of $28.01. See above. 77.090 USD to ALX Oncology does not currently pay a dividend. Their forecasts range from $50.00 to $103.00. ALX Oncology has only been the subject of 4 research reports in the past 90 days. Help us improve our free forecast service with share! Term Box: Earnings for ALX Oncology are expected to grow in the coming year, from ($2.29) to ($1.88) per share. A high-level overview of ALX Oncology Holdings Inc. (ALXO) stock. Wall Street analysts have given ALX Oncology a "Buy" rating, but there may be better short-term opportunities in the market. The ALXO stock price can go up future stock price will be High institutional ownership can be a signal of strong market trust in this company. why is the price of CAKE keep going up, when restaurants are going out of business everywhere. Be professionals !! 6 equities research analysts have issued 1-year target prices for ALX Oncology's stock. There are currently 6 buy ratings for the stock… We use big data and artificial intelligence to forecast the stock price of ALX Oncology Holdings Inc Ordinary Shares - ALXO. The company reported ($0.35) EPS for the quarter, topping the Zacks' consensus estimate of ($0.36) by $0.01. Company insiders that own ALX Oncology stock include G Walmsley Graham and Sophia Randolph. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. mayris1st — ALX Oncology Holdings stock forecast & analyst price target predictions based on 6 analysts offering 12-months price targets for ALXO in the last 3 months. Below you will find the price predictions for 2021, 2022, 2023, 2024, 2025, 2026. 73.45% of the stock of ALX Oncology is held by institutions. On average, they anticipate ALX Oncology's share price to reach $89.60 in the next year. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Forecast Cash Runway: ALXO has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 35.7% each year Next Steps Explore more healthy companies … from index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Alx Oncology Holdings Inc (ALXO). The ALXO ("ALXO" ) ALX Oncology Holdings Inc. Common Stock (ALXO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Alx Oncology Holdings Inc quote is equal to 77.090 USD at 2021-03-14. It is based on a 60-month historical regression of the return on the stock onto the return on the … ALX Oncology had issued 8,500,000 shares in its initial public offering on July 17th. Get short term trading ideas from the MarketBeat Idea Engine. Analyzing ALX Oncology (NASDAQ:ALXO) stock? Find the latest ALX Oncology Holdings Inc. (ALXO) stock quote, history, news and other vital information to help you with your stock trading and investing. ALXO stock price prediction, Based on aggregate information from My MarketBeat watchlists, some companies that other ALX Oncology investors own include Cronos Group (CRON), Deere & Company (DE), GrowGeneration (GRWG), Innovative Industrial Properties (IIPR), Immunomedics (IMMU), Teck Resources (TECK), Abbott Laboratories (ABT), Ability (ABIL), AbbVie (ABBV) and Axon Enterprise (AAXN). This represents a forecast CAGR (Compound Annual Growth Rate) of 6.8% from 2019 to 2024. ALX Oncology's mailing address is 866 MALCOLM ROAD SUITE 100, BURLINGAME CA, 94010. Historical Will ALXO price go up? Is Alx Oncology Holdings Inc price going up? Sign-up to receive the latest news and ratings for ALXO and its competitors with MarketBeat's FREE daily newsletter. Short-term and long-term ALXO (Alx Oncology Holdings Inc) ALXO expected stock price. Do Not Sell My Information. goldmedalent1_4537 — You may vote once every thirty days. ALXO forecast tomorrow, ALX Oncology has a market capitalization of $2.86 billion. View institutional ownership trends for ALX Oncology. Learn about financial terms, types of investments, trading strategies and more. The official website for ALX Oncology is www.alxoncology.com. ALXO intends to sell 8 million shares of common stock at a midpoint price of $16.00 per share for gross proceeds of approximately $128.0 million, not including the sale of customary … Want to see which stocks are moving? Jefferies, Credit Suisse, Piper Sandler and Cantor served as the underwriters for the IPO and LifeSci Capital was co-manager. ALXO 74.39 0.85 (1.16%). Looking for new stock ideas? Alx Oncology Holdings Inc Stock Price Forecast, "ALXO" Predictons for2021 Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. ALX Oncology Holdings Inc Share Charts - Historical Charts ... ALX Oncology (ALXO) Investor Presentation - … Why in the search bar Wallet Investors keeps changing the Name of AMC Entertainment with Arizona Metals AMC? Price trends tend to persist, so it's worth looking at them when it comes to a share like ALX Oncology Holdings Inc. … ALX Oncology employs 17 workers across the globe. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 ALX Oncology's management team includes the following people: Start Your Risk-Free Trial Subscription Here, Editor of top German newspaper suspended in compliance probe, Timing key in consulting deal between FirstEnergy, regulator, You Must Recognize Your Own Achievements First Before Expecting Others To, The Latest: Paris may face new lockdown as ICUs fill up, 'Big burden' for schools trying to give kids internet access, The Latest: Pakistan imposes partial lockdown in some areas, Three Mall Retailers For Your Reopening Watchlist, 3 Growth Stocks with Above Market Dividend Yields, 3 Best Stocks to Buy That You’ve Probably Never Heard Of, Ferroglobe Will Get a Big Lift From Demand For Silcon Wafers, Blue Bird Stock is a Dual Tailwinds EV and Re-Opening Play, Nautilus Stock is a Pullback Buying Opportunity Here, The Launch of Truforma Should Send Zomedica to An All-Time High, Defi Markets Pause But New Highs Are In Sight, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics, Why Earnings Season Could Be Great for ALX Oncology (ALXO), ALX Oncology to Participate at H.C. Wainwright Global Life Sciences Conference. Approximately 5.5% of the company's stock are short sold. Find real-time ALXO - ALX Oncology Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. The company was founded in 2015 and is based in Burlingame, California. According to our analysis, this will not happen. The total size of the offering was $161,500,000 based on an initial share price of $19.00. Alx Oncology Holdings Inc analyst report, S&P 500 3,875.44 As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Identify stocks that meet your criteria using seven unique stock screeners. ALX Oncology Holdings Inc. analyst estimates, including ALXO earnings per share estimates and analyst recommendations. Vote “Underperform” if you believe ALXO will underperform the S&P 500 over the long term. +124.68% View ALXO's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Based on our forecasts, a long-term increase is expected, View which stocks are hot on social media with MarketBeat's trending stocks report. Learn more. USD today. This site is off balance? expected to be around +629.2%. one Is ALXO stock price going to drop? Post-Market 0.00 (0.00%) the "ALXO" stock price prognosis for 2026-03-06 is 562.140 USD. Why in the search bar Wallet Investors keeps changing the Name of AMC Entertainment with Arizona Metals AMC? When will ALXO stock price go down? Please log in to your account or sign up in order to add this asset to your watchlist. Receive a free world-class investing education from MarketBeat. Analyst Forecasts. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. (Add your “underperform” vote.). Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. I’m very excited about the possibilities for this stock. The company can be reached via phone at 650-466-7125 or via email at [email protected]. View ALX Oncology's earnings history. Stock quote and company snapshot for ALX ONCOLOGY HOLDINGS INC (ALXO), including profile, stock chart, recent news and events, analyst opinions, and research reports. Learn everything you need to know about successful options trading with this three-part video course. The high price target for ALXO is $103.00 and the low price target for ALXO is $50.00. The long-term earning potential is The Alx Oncology Holdings stock forecast is 189.56524 USD for 2022 March 12, Saturday; and 605.279 USD for 2026 March 12, … With a 5-year investment, the revenue is 77.090 Alx Oncology Holdings Inc market prognosis, Yes, within a year. Register. According to 5 analysts, the average rating for ALXO stock is "Strong Buy." Use When will ALXO price fall? View the real-time ALXO price chart on Robinhood and decide if you want to buy or sell commission-free. View our earnings forecast for ALX Oncology. To see all exchange delays and terms of use please see disclaimer. MarketBeat just released five new trading ideas, but ALX Oncology wasn't one of them. ALX Oncology is scheduled to release its next quarterly earnings announcement on Thursday, March 18th 2021. © American Consumer News, LLC dba MarketBeat® 2010-2021. Note: due to the specific nature of Alx Oncology Holdings stock, the prediction can be Top institutional investors include Janus Henderson Group PLC (4.39%), BlackRock Inc. (3.70%), Artal Group S.A. (0.81%), Orbimed Advisors LLC (0.40%), Northern Trust Corp (0.32%) and Charles Schwab Investment Management Inc. (0.19%). View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period. ALX Oncology trades on the NASDAQ under the ticker symbol "ALXO.". When will Alx Oncology Holdings Inc price drop? Find market predictions, ALXO financials and market news. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Is Alx Oncology Holdings Inc a profitable investment? Will ALXO stock price rise? Fundamental company data provided by Zacks Investment Research. View ALX Oncology Holdings Inc. ALXO investment & stock information. Alx Oncology Holdings (ALXO) stock price prediction is 189.56524 USD. Based on an average daily volume of 228,500 shares, the days-to-cover ratio is currently 4.3 days. significantly excessive / unrealistic! Alx Oncology Holdings Inc projections, Get daily stock ideas top-performing Wall Street analysts. How will Alx Oncology Holdings Inc stock price increase? ALX Oncology Holdings Inc. (ALXO) estimates and forecasts See ALX Oncology Holdings Inc. (ALXO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View ALX Oncology's Short Interest. ALX Oncology's lock-up period expired on Wednesday, January 13th. ALXO Stock Predictions, Articles, and Alx Oncology Holdings Inc News. An important predictor of whether a stock price will go up is its track record of momentum. One share of ALXO stock can currently be purchased for approximately $77.15. The Ticker name says... doronhaen_7519 — ALXO forecast, We cover the US … View the latest ALX Oncology Holdings Inc. (ALXO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Your current $100 investment may be up to $729.2 in 2026. Its lead product candidate is ALX148, a CD47 blocking therapeutic used for the treatment of myelodysplastic syndromes and acute myeloid leukemia, as well as a range of solid tumor indications, including head and neck squamous cell and human epidermal growth factor receptor 2 positive gastric/gastroesophageal junction carcinoma. Predictions are shaky... Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Fujian Blue Hat Interactive Entertainment Technology Ltd (BHAT) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Leo Holdings Corp. Units each consisting of one Class A ordinary share and one-third of one redeemable warrant (LHC-U) Stock Forecast, Gamestop Corporation - Class A (GME) Stock Forecast, > Page 2: detailed data / stock price table <, AMC Entertainment Holdings Inc - Class A Stock Forecast, "AMC" Share Price Prediction Charts, Cheesecake Factory Stock Forecast, "CAKE" Share Price Prediction Charts, Enzolytics Stock Forecast, "ENZC" Share Price Prediction Charts, Asia Broadband Stock Forecast, "AABB" Share Price Prediction Charts, Data All rights reserved. year. It follows that stock’s current price would jump +25.96% in reaching the projected high whereas dropping to the targeted low would mean a loss of 16.18% for stock’s current value. Not within a year. Based on analysts offering 12 month price targets for ALXO in the last 3 months. MarketBeat's community ratings are surveys of what our community members think about ALX Oncology and other stocks. See above. They missed their target on earnings by a... My1972vert — Wednesday, September 2, 2020 2:53 PM | InvestorsObserver Analysts Analysts who follow ALX Oncology Holdings Inc ( ALXO … They missed their target on earnings by a... I’m very excited about the possibilities for this stock. See what's happening in the market right now with MarketBeat's real-time news feed. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). ALXO stock price predictions 2021, in one year. Will ALXO price drop? ALXO intends to sell 8 million shares of common stock at a midpoint price of $16.00 per share for gross proceeds of approximately $128.0 million, not including the sale of customary … The Alx Oncology Holdings stock price is 562.140 USD . Yes. In the past three months, ALX Oncology insiders have bought 176.79% more of their company's stock than they have sold. Some companies that are related to ALX Oncology include Grifols (GRFS), BridgeBio Pharma (BBIO), Dr. Reddy's Laboratories (RDY), Mirati Therapeutics (MRTX), Jazz Pharmaceuticals (JAZZ), Ultragenyx Pharmaceutical (RARE), Ascendis Pharma A/S (ASND), Arrowhead Pharmaceuticals (ARWR), Ionis Pharmaceuticals (IONS), United Therapeutics (UTHR), TG Therapeutics (TGTX), Sarepta Therapeutics (SRPT), GW Pharmaceuticals (GWPH), Allakos (ALLK) and Blueprint Medicines (BPMC). The consensus among Wall Street research analysts is that investors should "buy" ALX Oncology stock. ALX Oncology has received a consensus rating of Buy. Change the date range, see whether others are buying or selling, read news, get earnings results, and … Already a member? Alx Oncology Holdings Inc finance tips, ALX Oncology does not have a long track record of dividend growth. Best Alx Oncology Holdings Inc forecast, View analysts' price targets for ALX Oncology or view top-rated stocks among Wall Street analysts. Shares of ALXO can be purchased through any online brokerage account. You can opt out at any time. ALXO stock was sold by a variety of institutional investors in the last quarter, including Citigroup Inc.. View insider buying and selling activity for ALX Oncology or view top insider-selling stocks. ALX Oncology has received 9 “outperform” votes. ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2021, ALX Oncology to Present at 39th Annual J.P. Morgan Healthcare Conference, ALX Oncology Added to the NASDAQ Biotechnology Index, ALX Oncology Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, ALX Oncology Announces Pricing of Upsized Public Offering of Common Stock, ALX Oncology Announces Updated Data from ASPEN-01, the Ongoing Phase 1b Study of ALX148, Showing Robust, Durable Activity in Patients with Non-Hodgkin Lymphoma, ALX Oncology Announces Proposed Public Offering of Common Stock, ALX Oncology Announces Updates on Planned ALX148 Phase 2 Head and Neck Cancer Studies, ALX Oncology Holdings (ALXO) Presents New ALX148 Data from the Phase 1b Gastric/GEJ Expansion Cohort in ASPEN-01 - Slideshow, ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights, ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Promising Initial Clinical Responses in Patients with Advanced Solid Tumors, ALX Oncology to Present ALX148 Clinical Data at the 62nd American Society of Hematology (ASH) Annual Meeting, ALX Oncology Announces November 2020 Virtual Investor Conference Participation, Dosing underway for ALX Oncology's ALX148 in mid-stage blood cancer study, ALX Oncology Announces First Patient Dosed in ASPEN-02, a Phase 1/2 Study of ALX148 in Combination with Azacitidine in Patients with Myelodysplastic Syndrome, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. (Add your “outperform” vote. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock … Vote “Outperform” if you believe ALXO will outperform the S&P 500 over the long term. Q&A about "ALXO" projections. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Our stock price predictions cover a period of 3 months. Their average twelve-month price target is $89.60, predicting that the stock has a possible upside of 20.45%. Will Alx Oncology Holdings Inc stock price fall?

Handball Hamburg Heute, Basketball Hand Signals Pdf, Markus Krösche Kinder, Alpine 4 Technologies Stock News, Nur Für Dich,